The assay data is clearly a dud imo that's why it wasn't released. Results expected end of Sep 2018.
AUG 7th 2018
"Biotron has previously advised that a novel diagnostic assay is being utilised to demonstrate the potential impact of BIT225 on HIV-1 virus levels. The Company had expected results from this highly specialised virology assay to be available by mid 2018. This work is being done by a third party that has developed the assay and is completely independent from Biotron. They have indicated that there have been some delays due to other commitments and that the Biotron results are now expected by the end of September 2018. The samples and the results of the analyses remain blinded until this work is complete.
BIT Price at posting:
8.0¢ Sentiment: None Disclosure: Not Held
